Reuters logo
10 天前
BRIEF-Heron Therapeutics reports quarterly loss per share $0.80
2017年8月9日 / 晚上8点29分 / 10 天前

BRIEF-Heron Therapeutics reports quarterly loss per share $0.80

Aug 10 (Reuters) - Heron Therapeutics Inc-

* Heron Therapeutics reports financial results for the three and six months ended June 30, 2017 and recent corporate progress

* Quarterly loss per share $0.80

* Heron Therapeutics Inc - ‍has increased its full year 2017 net product sales of sustol guidance to a range of $25 to $30 million​

* Heron - ‍believes cash, cash equivalents and short-term investments provides co with funding sufficient to complete htx-011 phase 3 studies in h1 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below